Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity

PURPOSE: To investigate the efficacy of a novel treatment – intra-meibomian gland (MG) injection of the anti-VEGF agent bevacizumab – for MG dysfunction (MGD) with eyelid-margin vascularity. METHODS: A total of 26 eyes from 13 patients diagnosed with MGD and eyelid-margin vascularity were included i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xiaodan, Wang, Yuexin, Lv, Huibin, Liu, Yan, Zhang, Mingzhou, Li, Xuemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960246/
https://www.ncbi.nlm.nih.gov/pubmed/29805249
http://dx.doi.org/10.2147/DDDT.S146556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960246/
https://www.ncbi.nlm.nih.gov/pubmed/29805249
http://dx.doi.org/10.2147/DDDT.S146556

Ejemplares similares